NEWS / November 2019

Meeting in Budapest with H.E. Ass. Prof. Dr. Bounkong SYHAVONG M.D. – Minister of Health, Lao People’s Democratic Republic (left on the picture) to discuss cooperation in the field of clinical research and medical tourism.

NEWS / CR-Ventures

CRU Global network affiliate CR-Ventures Pte. Ltd. (Clinical Research Ventures) Launches New Fund to Support Early Trials. Clinical Research Ventures Pte Ltd, (CRV), a Singapore-­based firm, announced on 07 November 2019 a new global investment partnership specifically devoted to enabling and accelerating clinical development programs for life sciences companies. With a focus on pharmaceutical, device, and diagnostic assets entering Phase I and II trials, CRV intends to invest in up to 10 programs per year, which will leverage up to US$50 million annually in clinical trial and related costs. CRV is location-­agnostic, investing worldwide from offices located in Singapore, Frankfurt and Boston.

NEWS /November 2019

Meeting in Budapest with H.E. Ass. Prof. Dr. Bounkong SYHAVONG M.D. – Minister of Health, Lao People’s Democratic Republic (left on the picture) to discuss cooperation in the field of clinical research and medical tourism.

NEWS / CRU Global at BIOJAPAN 2019

CRU was represented and presented at BIOJAPAN in Yokohama 09 – 11 Sep 2019 and at European Biotech and Pharma partnering Conference, Osaka on 08 Oct 2019 in the organization of EU-Japan Centre for industrial Cooperation and the Enterprise Europe Network.

NEWS / September 2019

CRU opened its brand new facility in Hanoi in the 354 Military Hospital.

NEWS / January 2019

CRU become the full member of the EIT Health Network. EIT Health is a network of best-in-class health innovators backed by the EU. https://www.eithealth.eu/partners

NEWS / 2018

1.CRU awarded 2 research grants in the last 2 months of 2018:

        - GINOP-2.1.2-8-1-4-16 INNOSLEEP – Cost effective development of clinical sleep laboratory assessments with new, innovative

           technical solutions (245,597,220.- HUF+156,289,140.- HUF)

        - 2018-1.1.2-KFI Early diagnostic assessment tools in the cancer diagnostics based on metabolomics (329,704,090.- HUF)

2.CRU awarded in 2018 the Phase I part of an SME Instrument, Horizon 2020 European Union research grant for the project called: “The First End-to-End Clinical Trials Management and Remote Monitoring System”

 
 

NEWS / Pfizer certificate

NEWS / WorldWide TOP enroller in PCSK9 Cardiovascular Outcome study with 178 randomized subjects


NEWS / WorldWide TOP enroller in Phase IIa Antisense Glucagon Receptor Antagonist



NEWS / WorldWide TOP enroller in Phase III severe COPD study with biologics